AIMAH | Non-AIMAH | |||||||
---|---|---|---|---|---|---|---|---|
Dose | n | Partial response (%) | Full response (%) | Correlation with in vivotest | n | Partial response (%) | Full response (%) | |
ACTH1-24 | 50 pg/ml | 7 | 2 (29%) | 4 (57%) | 0.30 | 5 | 1 (20%) | 4 (80%) |
ACTH1-24 | 500 pg/ml | 10 | 3 (30%) | 6 (60%) | 0.07 | 18 | 1 (6%) | 16 (89%) |
FSK | 1 μM | 8 | 0 | 7 (88%) | 0.29 | 9 | 0 | 7 (78%) |
AngII | 10 nM | 2 | 0 | 0 | n.a. # | 2 | 1 (50%) | 1 (50%) |
AVP | 10 nM | 6 | 2 (33%) | 1 (17%) | −0.72†; -0.50# | 4 | 1 (25%) | 0 |
AVP | 100 nM | 4 | 1 (25%) | 1 (25%) | −1.00†; -0.80# | 3 | 1 (33%) | 0 |
Desmopressin | 10 nM | 5 | 0 | 0 | −0.80 | 3 | 0 | 0 |
Metoclopramide | 1 μM | 7 | 0 | 2 (29%) | 0.71 | 14 | 3 (21%) | 0 |
Epinephrine | 1 μM | 7 | 1 (14%) | 1 (14%) | −0.50# | 5 | 0 | 0 |
Norepinephrine | 1 μM | 7 | 1 (14%) | 0 | −0.15# | 5 | 0 | 0 |
hCG | 100 IU/ml | 10 | 3 (30%) | 0 | 0.60 | 4 | 0 | 0 |
TSH | 10 nM | 4 | 0 | 0 | −0.32 | 1 | 0 | 0 |
Glucagon | 1 μM | 4 | 0 | 0 | 0.50 | 1 | 0 | 0 |
GIP | 100 nM | 6 | 1 (17%) | 1 (17%) | 0.49¶ | 4 | 1 (25%) | 0 |